VTVT
vTv Therapeutics Inc.Company Information
- Company Name
- vTv Therapeutics Inc.
- CIK
- CIK0001641489
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VTVT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VTVT
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-11-18
- Last sale
- 2021-12-20
- Shares purchased (TTM)
- 1,844
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,601,113
- Shares outstanding
- 12,409,316
- Ownership
- 12.90%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -6.50%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Class A | 0 | 4 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 2 | 0 | 0 | ||||||
| Common Class B | -0 | 0 | 0 | -1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Related Party | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | - | 0 | - | ||||||
| Nonrelated Party | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | - | 0 | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 87 | 98 | 89 | 99 | 26 | 31 | 37 | 42 | 46 | 52 | 9 | 8 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 1 | 1 | 1 | 0 | 1 | 1 | - | - | - | - | - | ||||||
| Other Assets Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | - | - | 1 | - | - | - | 1 | 1 | 0 | 1 | 1 | 2 | ||||||
| Assets Current | 88 | 99 | 90 | 99 | 26 | 32 | 38 | 43 | 46 | 54 | 11 | 10 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 4 | ||||||
| Deposits Assets Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Assets | 88 | 99 | 90 | 99 | 26 | 32 | 38 | 43 | 46 | 54 | 11 | 15 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 7 | 7 | 7 | 10 | 5 | 4 | 5 | 6 | 7 | 9 | 10 | 10 | ||||||
| Operating Lease Liability Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | - | - | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 7 | 7 | 7 | 10 | 5 | 4 | 5 | 6 | 7 | 9 | 11 | 10 | ||||||
| Contract With Customer Liability Noncurrent | 2 | 2 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 9 | 9 | 25 | 29 | 24 | 23 | 24 | 25 | 26 | 28 | 30 | 29 | ||||||
Stockholders Equity | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 394 | 392 | 391 | 390 | 314 | 313 | 312 | 311 | 308 | 307 | 256 | 255 | ||||||
| Retained Earnings Accumulated Deficit | -316 | -303 | -327 | -320 | -311 | -305 | -300 | -296 | -291 | -286 | -281 | -281 | ||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 6 | 11 | ||||||
| Stockholders Equity | 79 | 90 | 64 | 71 | 2 | 8 | 12 | 18 | 16 | 26 | -25 | -25 | ||||||
| Minority Interest | - | - | 0 | 0 | -0 | 1 | 2 | 3 | 4 | 5 | 0 | - | ||||||
| Liabilities And Stockholders Equity | 88 | 99 | 90 | 99 | 26 | 32 | 38 | 43 | 46 | 54 | 11 | 15 | ||||||
| Common Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.01 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialvTv Therapeutics Inc. (VTVT) — SEC Financial Statements & Analysis
vTv Therapeutics Inc. (VTVT) is a pharmaceutical preparations company, incorporated in DE. vTv Therapeutics Inc. trades on Nasdaq as: VTVT. vTv Therapeutics Inc. (VTVT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, vTv Therapeutics Inc. carries a market cap of $467.21M, a P/E ratio of -52.72x, a P/B ratio of 5.94x, a P/S ratio of 12.68x, an enterprise value of $380.57M, and an EV/EBITDA multiple of -41.16x. On profitability, it posts an operating margin of -25.11%, a net margin of -24.06%, a Return on Equity (ROE) of -21.87%, and a Return on Assets (ROA) of -15.54%. Per share, it reports EPS of $-0.71, diluted EPS of $-0.71, free cash flow per share of $-1.35, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 216600.00% year-over-year, net income growth of -51.84% year-over-year, and EPS growth of -74.44% year-over-year. On the balance sheet, it maintains a current ratio of 12.48x, a quick ratio of 12.42x, working capital of $80.57M, a debt-to-equity ratio of 0.11x, a debt ratio of 0.1, an interest coverage ratio of -3427.86x, free cash flow of $-16.76M (TTM), and net debt of $-86.64M. Figures sourced from SEC EDGAR.
- Market Cap
- $467.21M
- P/E TTM
- -52.72x
- EPS TTM
- $-0.71
- P/B TTM
- 5.94x
- ROE TTM
- -21.87%
- ROA TTM
- -15.54%
- Debt To Equity
- 0.11x
- Free Cash Flow TTM
- $-16.76M
- Net Revenue TTM Growth 1Y
- 216600.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is vTv Therapeutics Inc. in?
vTv Therapeutics Inc. (VTVT) operates in the Pharmaceutical Preparations industry.
What exchange does VTVT trade on?
vTv Therapeutics Inc. (VTVT) trades on the Nasdaq.
Where is vTv Therapeutics Inc. incorporated?
vTv Therapeutics Inc. is incorporated in DE.
When was vTv Therapeutics Inc. (VTVT)'s most recent SEC filing?
vTv Therapeutics Inc. (VTVT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is VTVT's market cap?
vTv Therapeutics Inc. (VTVT) has a market capitalization of $467.21M as of 2026-06-30.
What is VTVT's EPS (earnings per share)?
vTv Therapeutics Inc. (VTVT)'s trailing twelve month EPS is $-0.71 as of 2026-06-30.
What is VTVT's ROE (return on equity)?
vTv Therapeutics Inc. (VTVT)'s trailing twelve month Return on Equity (ROE) is -21.87% as of 2026-06-30.
What is VTVT's ROA (return on assets)?
vTv Therapeutics Inc. (VTVT)'s trailing twelve month Return on Assets (ROA) is -15.54% as of 2026-06-30.
What is VTVT's EV/EBITDA?
vTv Therapeutics Inc. (VTVT)'s trailing twelve month EV/EBITDA is -41.16x as of 2026-06-30.